Novo Nordisk
Novo Nordisk is a Danish multinational pharmaceutical company that specializes in diabetes care and hormone replacement therapies. Founded in 1923, the company is known for its innovative insulin products and GLP-1 receptor agonists, such as Ozempic, which are used for managing diabetes and aiding in weight loss. Novo Nordisk has a strong commitment to research and development, particularly in the fields of diabetes, obesity, and hemophilia.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
Denmark:
Novo Nordisk has taken a new step towards maintaining its leading position in the market for treating severe obesity and diabetes.
8
Ecuador:
Novo Nordisk alerted about counterfeit diabetes medication.
7
Italy:
Novo Nordisk produces Ozempic and is also working on a pill for diabetes and obesity.
6
Argentina:
Novo Nordisk is the owner of the original Ozempic and has announced the arrival of Wegovy in Argentina.
6
Estonia:
Novo Nordisk's stock decreased by 1.3 percent.
5
Bulgaria:
The popular injection from Novo Nordisk is mentioned as a comparison for the new experimental pill from Eli Lilly.
8
Denmark:
Novo Nordisk has decided to significantly reduce the price of the weight loss drug Wegovy in the US market.
8
Russia:
Novo Nordisk is the Danish company that produces the drug Ozempic.
5